Gastrooesophageal cancer+1
RecruitingStudy on the Safety of Trifluridine/Tipiracil for Patients with Dihydropyrimidine Dehydrogenase Deficiency and Metastatic Colorectal or Gastroesophageal Cancer
Study on the Safety of Trifluridine/Tipiracil for Patients with Dihydropyrimidine Dehydrogenase Deficiency and Metastatic Colorectal or Gastroesophageal Cancer
- Disease:Gastrooesophageal cancerColorectal cancer metastatic
- Substances:BevacizumabNivolumab+7
France- Participants:18–64 years · 65+ years
- Substances:Bevacizumab
